-
The race to the bottom: intensive LDL-C lowering in very high-risk Asian patients
Ade Meidian Ambari University of Indonesia, Indonesia 14:30~14:50 -
Combination therapy in high-risk patients: early vs stepwise approach
Han Na Jung Hallym University, Republic of Korea 14:50~15:10 -
Practical approaches to statin intolerance: from clinical trials to real-world solutions
Jung-Joon Cha Korea University, Republic of Korea 15:10~15:30 - Panel Discussion 15:30~16:00
-
Do East Asians need lower statin intensity? ethnic differences in LDL-C response and safety
Eun Jeong Cho Chung-Ang University, Republic of Korea 16:10~16:28 -
Why TG is important in Asians?
Daisaku Masuda Rinku General Medical Center, Japan 16:28~16:46 -
Genetic stratification and treatment response in Korean severe hypertriglyceridemia: a prospective multicenter registry study
Hun Jee Choe Hallym University, Republic of Korea 16:46~17:04 -
Chylomicronemia: past, present and future
Hiroaki Okazaki Teikyo University, Japan 17:04~17:22 - Panel Discussion 17:22~17:40
-
Lipoprotein(a) in Korean patients: real-world data, cardiovascular risk, and clinical implications
Sang Min Park Eulji University, Republic of Korea 13:45~14:05 -
Lipoprotein(a) and coronary atherosclerosis in Vietnam: real-world data and emerging cardiovascular risk
Tien Hoang Anh Hue University, Vietnam 14:05~14:25 -
Measuring Lipoprotein(a) in clinical practice: assay challenges, standardization, and interpretation
Sang Guk Lee Yonsei University, Republic of Korea 14:25~14:45 - Panel Discussion 14:45~15:15
-
The emerging role of ApoB and triglyceride-rich lipoproteins
Sin Yung Woo Konyang University, Republic of Korea 08:50~09:10 -
Beyond LDL-C: targeting inflammation and lipoprotein(a) to address residual cardiovascular risk in Asia
Ping-Yen Liu National Cheng Kung University, Taiwan 09:10~09:30 -
Cardiometabolic residual risk in Asia: diabetes, metabolic dysfunction, and vascular aging
Minkwan Kim Yonsei University, Republic of Korea 09:30~09:50 - Panel Discussion 09:50~10:20
-
Dyslipidemia across ethnicities in Malaysia: who is at risk, and who is being left behind?
Nor Ashikin Md Sari University of Malaya, Malaysia 08:50~09:10 -
Genetic architecture of dyslipidemia and cardiovascular risk in East Asians: from monogenic variants to polygenic risk
Soo Heon Kwak Seoul National University, Republic of Korea 09:10~09:30 -
Epidemiological trends of dyslipidemia in Korea and their implications for Asian populations
Ho Kyou Lee Yonsei University, Republic of Korea 09:30~09:50 - Panel Discussion 09:50~10:20
-
ESC/EAS dyslipidemia guidelines: recent updates and evidence base
Meral Kayikcioglu Ege University, Türkiye 15:40~16:00 -
Korean perspectives on dyslipidemia guidelines: recent update and challenges
Jaehoon Chung Gachon University, Republic of Korea 16:00~16:20 -
Translating guidelines into practice
Wonjin Kim Cha University, Republic of Korea 16:20~16:40 - Panel Discussion 16:40~17:10
